Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CYR61 |
| Upstream (Parents) |
|---|
| (<<) HEG1 → CYR61 |
| (<<) ENTPD1 → CYR61 |
| (<<) LOXL1 → CYR61 |
| (<<) PTRF → CYR61 |
| (<<) COL4A1 → CYR61 |
| (<<) VEGFC → CYR61 |
| Downstream (Children) |
|---|
| CYR61 → NHLH1 (>>) |
| CYR61 → C20orf117 (>>) |
| CYR61 → MYO9B (>>) |
| CYR61 → ADA (>>) |
| CYR61 → LRRN2 (>>) |
| CYR61 → ALDH1A3 (>>) |
| CYR61 → PCDHGA3///PCDHGA5///PCDHGA6///PCDHGA10///PCDHGA11///PCDHGA12 (>>) |
| CYR61 → TUBB4Q (>>) |
| CYR61 → RARRES1 (>>) |
| CYR61 → ITIH5 (>>) |
| CYR61 → CHST3 (>>) |
| CYR61 → FAM55C (>>) |
| CYR61 → IL6 (>>) |
| CYR61 → HIPK3 (>>) |
| CYR61 → C6orf25 (>>) |
| CYR61 → HSPA2 (>>) |
| CYR61 → GAS6 (>>) |
| CYR61 → IL17RB (>>) |
| CYR61 → DAB1 (>>) |
| CYR61 → PDLIM7 (>>) |
| CYR61 → DUX1 (>>) |
| CYR61 → CTBP1 (>>) |
| CYR61 → KCNC3 (>>) |
| CYR61 → DUSP9 (>>) |
